Hepatocellular carcinoma: systemic therapies and future perspectives.
about
Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implicationsPhase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.Disparities in care for patients with curable hepatocellular carcinomaHepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011).A preliminary study of ALPPS procedure in a rat model.Laparoscopic liver resection for hepatitis B and C virus-related hepatocellular carcinoma in patients with Child B or C cirrhosisThe miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer.miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma.Nanomedicines: a theranostic approach for hepatocellular carcinoma.The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.In Vitro and In Vivo Anticancer Activity of Gimatecan against Hepatocellular CarcinomaSTAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC.Management of pediatric hepatocellular carcinoma: A multimodal approach.Association Between a Variant in ADAMTS5 and the Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population.
P2860
Q28384501-1847DE63-688B-44E9-A24F-D7A206FC0390Q33433311-6B3DA89E-FCEE-4FFB-9F25-898EC7019109Q36019636-A93390E8-707A-4B46-9EC5-69C629722BE1Q36339568-D01FA80D-31C4-4F06-85D5-9B6C17A2A294Q36343340-435274CC-D494-458F-BD3D-3F7DB19B8F35Q36400025-1F04F918-CDF5-45F0-B451-D24D7074E290Q37683757-84491534-D0F2-437D-A93E-52BB410825B4Q38834174-5254C4A6-4D94-460C-9943-5C2DF77B81BFQ40011787-1B7139B1-480C-4DE2-9586-D5256B848223Q40051560-B58F2ECB-3FA0-4A78-BCB1-12DD55B2888FQ40625859-DD487F13-314D-40CC-A2AB-CA92BEB7753FQ41835434-64EEB97D-46C8-49EC-908E-01E98BF62C76Q47122059-3ADBB097-5180-4B93-886C-989E455BC2AAQ48252418-D272FBAB-6008-4F87-A086-B9AAA24325A1Q53658904-253B98ED-8AF3-45B4-A90D-7622B1534BFA
P2860
Hepatocellular carcinoma: systemic therapies and future perspectives.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hepatocellular carcinoma: systemic therapies and future perspectives.
@en
type
label
Hepatocellular carcinoma: systemic therapies and future perspectives.
@en
prefLabel
Hepatocellular carcinoma: systemic therapies and future perspectives.
@en
P2093
P2860
P1476
Hepatocellular carcinoma: systemic therapies and future perspectives.
@en
P2093
Amer Zeidan
David Cosgrove
Sameh Mikhail
P2860
P304
P356
10.1586/14737140.2014.949246
P577
2014-09-09T00:00:00Z